What is Nektar Therapeutics's earnings yield?

Nektar Therapeutics (NKTR) reported earnings yield of -7.7% in Q1 2026.

How has Nektar Therapeutics's earnings yield changed year-over-year?

Nektar Therapeutics's earnings yield increased by 93.1% year-over-year, from -110.9% to -7.7%.

What is the long-term trend for Nektar Therapeutics's earnings yield?

Over 5 years (2020 to 2025), Nektar Therapeutics's earnings yield has grown at a 6.1% compound annual growth rate (CAGR), from -14.2% to -19.1%.

What does earnings yield mean?

Trailing-twelve-month net income divided by market capitalization at the quarter end — the inverse of the P/E ratio, expressed as a percentage.

Nektar Therapeutics NKTR Earnings yield

Earnings yield at other companies

AmgenAMGN

4.1%+0.6pp

Regeneron PharmaceuticalsREGN

5.4%-1.1pp

ImmunityBio, Inc.IBRX

-10.8%-2.6pp

Apogee Therapeutics, Inc.APGE

-4.4%-1.5pp

ImmunomeIMNM

-9.1%-3.9pp

Vera TherapeuticsVERA

-12.9%+1.8pp

Other financials

Income statement

See full

Revenue$10.9M+3.8%

Gross profit$21.8M+2.9%

Operating income-$39.1M+12.3%

Net income-$44.9M+11.7%

EPS (diluted)-$1.82+49.7%

Balance sheet

See full

Cash & equivalents$5.7M-20.0%

Total debt$83.2M-17.1%

Total equity$576.2M+4,094%

Total assets$763.3M+198%

Cash flow

See full

Operating cash flow-$44.3M+9.7%

CapEx$18.0K+800%

Free cash flow-$44.3M+9.7%

Valuation

See full

Market cap$2.25B+1,531%

Enterprise value$2.33B+874%

P/S40.5×+38.9×

Profitability

See full

Gross margin100%+31.2pp

Operating margin-242%—

Net margin-284.2%+937pp

FCF margin-366.6%+1,421pp

Returns & leverage

See full

Return on equity-53.6%-22.6pp

Debt / equity0.1×-7.2×

Current ratio10.2×+7.0×

Where this comes from

Calculated from Nektar Therapeutics’s reported figures.

net income/market cap=-7.7%

Based on trailing twelve months.

The official record: Nektar Therapeutics’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Nektar Therapeutics's earnings yield.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Nektar Therapeutics's earnings yield?: Nektar Therapeutics (NKTR) reported earnings yield of -7.7% in Q1 2026.
How has Nektar Therapeutics's earnings yield changed year-over-year?: Nektar Therapeutics's earnings yield increased by 93.1% year-over-year, from -110.9% to -7.7%.
What is the long-term trend for Nektar Therapeutics's earnings yield?: Over 5 years (2020 to 2025), Nektar Therapeutics's earnings yield has grown at a 6.1% compound annual growth rate (CAGR), from -14.2% to -19.1%.
What does earnings yield mean?: Trailing-twelve-month net income divided by market capitalization at the quarter end — the inverse of the P/E ratio, expressed as a percentage.